Hiremii Ltd
ASX:HMI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hiremii Ltd
ASX:HMI
|
AU |
|
Vyne Therapeutics Inc
NASDAQ:VYNE
|
US |
|
C
|
China Sanjiang Fine Chemicals Co Ltd
HKEX:2198
|
CN |
|
Sanwei Holding Group Co Ltd
SSE:603033
|
CN |
|
V V Food & Beverage Co Ltd
SSE:600300
|
CN |
Income Statement
Earnings Waterfall
Hiremii Ltd
Income Statement
Hiremii Ltd
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
7
N/A
|
7
+5%
|
11
+57%
|
17
+49%
|
21
+22%
|
26
+24%
|
30
+17%
|
31
+3%
|
30
-3%
|
31
+3%
|
|
| Gross Profit | |||||||||||
| Cost of Revenue |
0
|
(4)
|
(10)
|
(15)
|
(18)
|
(23)
|
(27)
|
(28)
|
(27)
|
(28)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
1
+251%
|
2
+76%
|
2
+19%
|
3
+12%
|
3
+10%
|
3
+2%
|
3
-6%
|
3
+3%
|
|
| Operating Income | |||||||||||
| Operating Expenses |
(11)
|
(8)
|
(4)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
|
| Selling, General & Administrative |
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
|
| Research & Development |
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(7)
|
(3)
|
0
|
1
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
|
| Operating Income |
(4)
N/A
|
(4)
-9%
|
(2)
+39%
|
(1)
+56%
|
(1)
-16%
|
(1)
-11%
|
(1)
+40%
|
(1)
+15%
|
(1)
-51%
|
(1)
-2%
|
|
| Pre-Tax Income | |||||||||||
| Interest Income Expense |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(4)
-17%
|
(3)
+38%
|
(1)
+61%
|
(2)
-39%
|
(2)
-7%
|
(1)
+43%
|
(1)
+15%
|
(1)
-48%
|
(1)
-2%
|
|
| Net Income | |||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(4)
|
(4)
|
(3)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Net Income (Common) |
(4)
N/A
|
(4)
-17%
|
(3)
+38%
|
(1)
+61%
|
(2)
-39%
|
(2)
-7%
|
(1)
+43%
|
(1)
+15%
|
(1)
-48%
|
(1)
-2%
|
|
| EPS (Diluted) |
-0.06
N/A
|
-0.06
N/A
|
-0.03
+50%
|
-0.01
+67%
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
-0.01
N/A
|
|